Authors’ response to Braillon’s comment on: “Limited evidence for risk factors for Proarrhythmia and sudden cardiac death in patients using antidepressants: Dutch consensus on ECG monitoring”

Mirjam Simoons, Adrie Seldenrijk, Hans Mulder, Eric van Roon, Roberto Bakker, Henricus Ruhé

Research output: Contribution to journalLetterAcademic

Original languageEnglish
Pages (from-to)1417-1418
Number of pages2
JournalDrug Safety
Volume41
Issue number12
DOIs
Publication statusPublished - 1 Dec 2018

Cite this

@article{bd6c878c64e24bcd93bc1069361051c9,
title = "Authors’ response to Braillon’s comment on: “Limited evidence for risk factors for Proarrhythmia and sudden cardiac death in patients using antidepressants: Dutch consensus on ECG monitoring”",
author = "Mirjam Simoons and Adrie Seldenrijk and Hans Mulder and {van Roon}, Eric and Roberto Bakker and Henricus Ruh{\'e}",
year = "2018",
month = "12",
day = "1",
doi = "10.1007/s40264-018-0716-5",
language = "English",
volume = "41",
pages = "1417--1418",
journal = "Drug Safety",
issn = "0114-5916",
publisher = "Adis International Ltd",
number = "12",

}

Authors’ response to Braillon’s comment on : “Limited evidence for risk factors for Proarrhythmia and sudden cardiac death in patients using antidepressants: Dutch consensus on ECG monitoring”. / Simoons, Mirjam; Seldenrijk, Adrie; Mulder, Hans; van Roon, Eric; Bakker, Roberto; Ruhé, Henricus.

In: Drug Safety, Vol. 41, No. 12, 01.12.2018, p. 1417-1418.

Research output: Contribution to journalLetterAcademic

TY - JOUR

T1 - Authors’ response to Braillon’s comment on

T2 - “Limited evidence for risk factors for Proarrhythmia and sudden cardiac death in patients using antidepressants: Dutch consensus on ECG monitoring”

AU - Simoons, Mirjam

AU - Seldenrijk, Adrie

AU - Mulder, Hans

AU - van Roon, Eric

AU - Bakker, Roberto

AU - Ruhé, Henricus

PY - 2018/12/1

Y1 - 2018/12/1

UR - http://www.scopus.com/inward/record.url?scp=85052500977&partnerID=8YFLogxK

U2 - 10.1007/s40264-018-0716-5

DO - 10.1007/s40264-018-0716-5

M3 - Letter

VL - 41

SP - 1417

EP - 1418

JO - Drug Safety

JF - Drug Safety

SN - 0114-5916

IS - 12

ER -